Navigation Links
First Patient Enrolled in SARcode Bioscience's Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution
Date:9/14/2011

ented Edward Holland, MD, a cornea specialist from the Cincinnati Eye Institute and consultant to SARcode Bioscience.  "It is exciting to see this new molecular entity, which was specifically designed for ocular use, enter pivotal trials.  If the Phase 3 program is successful, this novel therapy will provide a much needed treatment option that not only alleviates the symptoms of dry eye, but also improves visual-related quality-of-life for patients suffering from this disease."

SARcode Bioscience anticipates completion of the OPUS-1 study and topline data in mid-year 2012.

About Dry Eye Disease

Dry eye disease is a prevalent and often chronic condition estimated to affect approximately 20 million people in the US.  This number is expected to grow substantially in the next decade due to an aging population and increased incidence of type 2 diabetes, both of which contribute to higher rates of this condition. Dry eye disease is among the most common disorders treated by ophthalmologists throughout the world, and has been shown to have a significant impact upon quality-of-life.  Dry eye varies in severity and etiology, and symptoms most commonly manifest as discomfort, visual disturbances, and tear film instability due to decreased quality or quantity of tears.  A major contributing factor towards the development of dry eye is inflammation caused by T-cell infiltration, proliferation and inflammatory cytokine production that can lead to reduction in tear film quality and ocular surface damage.

About SAR 1118

SAR 1118 is a potent novel small molecule lymphocyte function-associated antigen-1 (LFA-1) antagonist under investigation for a broad range of ocular inflammatory conditions including dry eye and diabetic macular edema. LFA-1 is member of the integrin family of adhesion receptors found on the surface of all leukocytes and represents a therapeutic target central to a number of inflammatory sti
'/>"/>

SOURCE SARcode Bioscience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... SAN JOSE, Calif. , June 29, 2015 ... its expert medical workstation lineup. The high-powered, multi-functional ... th generation Intel® Haswell Core ... processor. Both provide significant data processing and computing ... visual performance, making the unit well suited for ...
(Date:6/29/2015)... June 29, 2015  Sorrento Therapeutics, Inc. (NASDAQ: ... added to the Russell 2000® Small Cap, Russell 3000®, ... occurred at the close of trading on June 26, ... set of U.S. and global indexes. Sorrento is already ... About the Russell Indexes. Russell ...
(Date:6/29/2015)... , June 29, 2015 /PRNewswire/-- CytRx Corporation (NASDAQ: ... specializing in oncology, today announced the presentation of interim ... evaluating the efficacy and safety of aldoxorubicin for the ... data will be presented on Wednesday, July 1, 2015 ... on Kaposi,s Sarcoma Herpesvirus (KSHV) and Related Agents in ...
Breaking Medicine Technology:Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 2Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 3CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 2CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 3CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 4CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 5CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 6
... GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an ... Human Immunodeficiency Virus (HIV) infections, announced today the completion ... its HIV/AIDS vaccine. The vaccine is being developed for ... be exposed to the virus. The trial, designated HVTN ...
... CIVCO Medical Solutions is pleased to announce the ... Advanced Robotics and Workflow Solutions. Ramirez will be ... Robotic Patient Positioning System and RFSuite RFID Tracking ... http://photos.prnewswire.com/prnh/20110419/AQ85801LOGO ) "CIVCO is a leader ...
Cached Medicine Technology:GeoVax Phase 2a Clinical Trial Completes Enrollment 2GeoVax Phase 2a Clinical Trial Completes Enrollment 3GeoVax Phase 2a Clinical Trial Completes Enrollment 4CIVCO Appoints Andres Ramirez Sales Director of Advanced Robotics and Workflow Solutions 2
(Date:6/30/2015)... ... ... It has become fairly common to purchase fresh broccoli at the grocery store, ... Throwing out radish greens, beet leaves and chard stalks is pretty typical, too. These ... little knowledge and practice to use them. Josie's Organics is setting out ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Skin Brushing (also known as Body Brushing) ... keep skin optimal and beautiful as it is more exposed to the elements. , Dry ... , Exfoliate the dead cells and toxins on skin's surface. Skin ...
(Date:6/30/2015)... ... ... Lecrae is quickly developing into one of the biggest music stories of ... Times to Billboard Magazine and Variety, among others. His transparency and honest lyrics ... many people are taking notice. , “We are very excited about this event! Lecrae ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... 2.0 EHR, a SaaS electronic health records system from the company exclusively dedicated ... software, Medflow 2.0 delivers an intuitive state-of-the-art solution combining modern cloud technology with ...
(Date:6/30/2015)... Diego, CA (PRWEB) , ... June 30, 2015 , ... ... owner and founder of SunGrubbies.com. “We are particularly interested in getting the word ... can take years to surface. We are extremely pleased with our new ...
Breaking Medicine News(10 mins):Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4Health News:Back in Stock: Keep Skin and Lymphatic System Healthy with Dry Skin Brushes from Sublime Beauty® 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3
... To be realistic and predictive, biological models need to ... to between cells to whole organs and beyond. The ... host a tutorial May 18-21, 2011, to introduce a ... and reaction kinetics network models as well as the ...
... , THURSDAY, Jan. 6 (HealthDay News) -- ... national guidelines for the treatment of potentially deadly methicillin-resistant ... health- care facilities, MRSA infections have become an increasing ... 60 percent of all skin infections treated in emergency ...
... technology that relies on thousands of synthetic molecules to fish ... detecting Alzheimer,s disease with a simple blood test. The same ... according to the report in the January 7th issue of ... "If this works in Alzheimer,s disease, it suggests it is ...
... disorder (ADHD) have shown for the first time why ... concentrating. The study, by experts at The University of ... child can maintain concentration when they are doing something ... Using a ,Whac-a-Mole, style game, researchers from the Motivation, ...
... Maureen Salamon HealthDay Reporter , THURSDAY, Jan. 6 ... such as pain, reduced flexibility and sleep disturbances than those ... the good news is that losing weight may bring a ... issues are common in obese people, researchers from the University ...
... A simpler form of testing individuals with risk ... substantially increasing the number of individuals who complete testing ... develop diabetes. Approximately 60 million Americans, one-third of ... individuals will develop Type 2 diabetes in less than ...
Cached Medicine News:Health News:Guidelines Issued for Drug-Resistant Staph Infections 2Health News:A blood test for Alzheimer's disease? 2Health News:A blood test for Alzheimer's disease? 3Health News:Faulty 'off-switch' stops children with ADHD from concentrating 2Health News:Faulty 'off-switch' stops children with ADHD from concentrating 3Health News:Study Links Obesity to Greater Pain, Weakness in Fibromyalgia Patients 2Health News:Study Links Obesity to Greater Pain, Weakness in Fibromyalgia Patients 3Health News:Routine blood test may identify people with pre-diabetes, cutting later treatment costs 2Health News:Routine blood test may identify people with pre-diabetes, cutting later treatment costs 3
... The TACIT Threaded Anchor ... used in craniofacial and ... easy, secure tissue reattachment ... suspension. The small size ...
ROC XS is a polyethylene implant used for soft tissue reattachment to bone. The umbrella-like deployment of this anchor provides increased fixation strength. This anchor is easy-to-insert using the R...
... SuperAnchors are titanium alloy implants ... to bone. They are indicated ... required. The SuperAnchor uses four ... while maintaining small size. The ...
The Mini-Revo suture anchor is designed primarily for arthroscopic and open Bankart shoulder repair. Additional applications include other shoulder repair procedures, as well as use in small joints....
Medicine Products: